5-hydroxytryptamine medications for the treatment of obesity.

5-hydroxytryptamine medications for the treatment of obesity.

Item
http://www.wikidata.org/entity/Q38449992
Hunger and Satiety Mechanisms and Their Potential Exploitation in the Regulation of Food IntakeControl of Body Weight by Eating Behavior in ChildrenSerotonin Deficiency Rescues Lactation on Day 1 in Mice Fed a High Fat Diet.Increased alternate splicing of Htr2c in a mouse model for Prader-Willi syndrome leads disruption of 5HT2C receptor mediated appetite.A Life without Hunger: The Ups (and Downs) to Modulating Melanocortin-3 Receptor Signaling.Activation of Ventral Tegmental Area 5-HT2C Receptors Reduces Incentive Motivation.Lorcaserin Hcl for the treatment of obesity.Epidemiology of Obesity and Pharmacologic Treatment Options.mTORC1 in AGRP neurons integrates exteroceptive and interoceptive food-related cues in the modulation of adaptive energy expenditure in mice.Lorcaserin improves glycemic control via a melanocortin neurocircuit.Role of impulsivity and reward in the anti-obesity actions of 5-HT2C receptor agonists.Lorcaserin and CP-809101 reduce motor impulsivity and reinstatement of food seeking behavior in male rats: Implications for understanding the anti-obesity property of 5-HT2C receptor agonists.
P2860

5-hydroxytryptamine medications for the treatment of obesity.

Item
http://www.wikidata.org/entity/Q38449992
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
5-hydroxytryptamine medications for the treatment of obesity.
@en
type
label
5-hydroxytryptamine medications for the treatment of obesity.
@en
prefLabel
5-hydroxytryptamine medications for the treatment of obesity.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
5-hydroxytryptamine medications for the treatment of obesity.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921